Deeptech factory
Diagnostics for life
VitaDX, created in 2015, is developing an innovative solution for the early detection of bladder cancer based on a patented technology which combines image processing and artificial intelligence.
CEO: Fabrice Beauchêne
Creation : april 2015
Headcount: 17
TECHNO / PRODUCTS
VitaDX develops software incorporating machine learning and deep learning algorithms to assess the morphological characteristics of cells for early detection of cancer.
PRODUCTS PORTFOLIO
APPLICATIONS
VisioCyt® Bladder is an IVDR CE-marked test for the diagnosis and monitoring of bladder cancer.
Performed on a simple urine sample and prior to endoscopy, this non-invasive test enables urologists to receive the results of a sensitive, reliable, reproducible analysis, combined with the expertise of the pathologist, for personalized patient management.
BENEFITS
VisioCyt® is the only test based on a patented method for analyzing cells present in urine, coupled with artificial intelligence, to detect cellular alterations at an early stage of malignancy.
This automated, reproducible solution will significantly improve diagnostic performance compared with conventional practices, while remaining in line with current clinical practice.
VITADX MINUTE
